Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
ConclusionOne-third of all-comers patients with CHD showed increased levels of hsCRP despite a LDL-cholesterol< 70 mg/dl potentially qualifying for an anti-inflammatory therapy. Elevated proBNP is an independent risk factor for hsCRP elevation.Graphic abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Chemotherapy | Cholesterol | Coronary Heart Disease | Eating Disorders & Weight Management | Heart | Heart Disease | Obesity | Pregnancy | Smokers | Study | Vytorin | Zetia